Utah Medical Products Stock Today

UTMD Stock  USD 57.41  0.24  0.42%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Utah Medical is trading at 57.41 as of the 21st of March 2025, a 0.42 percent decrease since the beginning of the trading day. The stock's lowest day price was 57.14. Utah Medical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
8th of March 1999
Category
Healthcare
Classification
Health Care
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 3.34 M outstanding shares of which 71.71 K shares are at this time shorted by private and institutional investors with about 2.84 trading days to cover. More on Utah Medical Products

Moving against Utah Stock

  0.84CMRX Chimerix Sell-off TrendPairCorr
  0.77JNJ Johnson JohnsonPairCorr
  0.72T ATT Inc Earnings Call This WeekPairCorr
  0.71VZ Verizon CommunicationsPairCorr
  0.61MCD McDonaldsPairCorr
  0.59NVRO Nevro CorpPairCorr

Utah Stock Highlights

ESG Sustainability
Environmental
Governance
Social
ChairmanKevin Cornwell
Thematic IdeaOffice Supplies (View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite Total, Office Supplies, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Average Analyst Recommendation
Debt Levels
Utah Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Utah Medical's financial leverage. It provides some insight into what part of Utah Medical's total assets is financed by creditors.
Liquidity
Utah Medical Products currently holds 295 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Utah Medical Products has a current ratio of 13.17, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Utah Medical's use of debt, we should always consider it together with its cash and equity.

Change To Inventory

(572,850)
Utah Medical Products (UTMD) is traded on NASDAQ Exchange in USA. It is located in 7043 South 300 West, Midvale, UT, United States, 84047-1048 and employs 4 people. Utah Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 191.47 M. Utah Medical Products conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 3.34 M outstanding shares of which 71.71 K shares are at this time shorted by private and institutional investors with about 2.84 trading days to cover. Utah Medical Products currently holds about 69.51 M in cash with 22.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.17.
Check Utah Medical Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Utah Medical is $191.47 Million. The majority of Utah Medical Products outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Utah Medical to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Utah Medical Products. Please pay attention to any change in the institutional holdings of Utah Medical Products as this could imply that something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Utah Ownership Details

Utah Stock Institutional Holders

InstituionRecorded OnShares
Minerva Advisors Llc2024-12-31
78.4 K
Hotchkis & Wiley Capital Management Llc2024-12-31
75.2 K
Bank Of New York Mellon Corp2024-12-31
47.3 K
Acadian Asset Management Llc2024-12-31
43.2 K
Royce & Associates, Lp2024-12-31
42 K
Northern Trust Corp2024-12-31
36.8 K
Morgan Stanley - Brokerage Accounts2024-12-31
36.4 K
Millennium Management Llc2024-12-31
32.1 K
Isthmus Partners Llc2024-12-31
31.5 K
Renaissance Technologies Corp2024-12-31
221.5 K
Dimensional Fund Advisors, Inc.2024-12-31
186.7 K
View Utah Medical Diagnostics

Utah Medical Historical Income Statement

At present, Utah Medical's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Selling And Marketing Expenses is expected to grow to about 1.5 M, whereas Total Revenue is forecasted to decline to about 36.6 M. View More Fundamentals

Utah Stock Against Markets

When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.27)
Dividend Share
1.205
Earnings Share
3.96
Revenue Per Share
11.677
Quarterly Revenue Growth
(0.26)
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.